THE ROLE OF NEUROTROPHINS AND ANGIOGENIC CYTOKINES IN THE PATHOPHYSIOLOGY OF PERIPHERAL NEUROPATHY IN PATIENTS WITH MULTIPLE MYELOMA

被引：0
|
作者：
Luczkowska, K. [1 ]
Litwinska, Z. [1 ]
Pius-Sadowska, E. [1 ]
Sobus, A. [1 ]
Paczkowska, E. [1 ]
Machalinski, B. [1 ]
机构：
[1] Pomaranian Med Univ Szczecin, Dept Gen Patol, Szczecin, Poland
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1937
引用
收藏
页码：773 / 773
页数：1
相关论文
共 50 条
  • [21] The Potential Role of Proinflammatory Cytokines and Complement Components in the Development of Drug-Induced Neuropathy in Patients with Multiple Myeloma
    Luczkowska, Karolina
    Rutka, Magdalena
    Roginska, Dorota
    Paczkowska, Edyta
    Baumert, Bartlomiej
    Milczarek, Slawomir
    Gorska, Martyna
    Kulig, Piotr
    Osekowska, Bogumila
    Janowski, Michal
    Safranow, Krzysztof
    Sommerfeld, Krzysztof
    Borowiecka, Ewa
    Zawodny, Piotr
    Koclega, Anna
    Helbig, Grzegorz
    Machalinski, Boguslaw
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
  • [22] THE ROLE OF FLT3-LIGANT IN THE PROGRESSION OF MULTIPLE MYELOMA: CORRELATION WITH ANGIOGENIC CYTOKINES.
    Kokonozaki, M.
    Devetzoglou, M.
    Tsirakis, G.
    Vasilokonstantaki, C.
    Stagakis, I.
    Psarakis, F.
    Moraitaki, E.
    Nioti, E.
    Alexandrakis, M.
    HAEMATOLOGICA, 2015, 100 : 730 - 730
  • [23] Burden of Treatment-Induced Peripheral Neuropathy in Patients with Multiple Myeloma in Sweden
    Nahi, Hareth
    Walinder, Goran
    Patel, Vishal
    Qu, Ying
    Levine, Aaron
    Majer, Istvan
    Kutikova, Lucie
    Hellqvist Franck, Eva
    Svensson, Maria K.
    Hansson, Markus
    ACTA HAEMATOLOGICA, 2021, 144 (05) : 519 - 527
  • [24] Risk Factor Analysis of Bortezomib Induced Peripheral Neuropathy in Patients with Multiple Myeloma
    Turgut, Nilda
    Turgut, Burhan
    Tekinalp, Atakan
    Erdogan, Hasan
    Kurtulus, Nursen
    Cicek, Emre
    ANNALS OF NEUROLOGY, 2014, 76 : S68 - S68
  • [25] Peripheral Neuropathy Experience in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Carfilzomib
    Martin, Thomas G.
    ONCOLOGY-NEW YORK, 2013, 27 : 4 - 10
  • [26] COSTS ASSOCIATED WITH TREATMENT INDUCED PERIPHERAL NEUROPATHY IN PATIENTS WITH MULTIPLE MYELOMA (MM)
    Panjabi, S.
    Song, X.
    Wilson, K.
    Kagan, J.
    VALUE IN HEALTH, 2016, 19 (07) : A708 - A708
  • [27] Comparison of Peripheral Neuropathy Between the Original and a Generic Bortezomib in Multiple Myeloma Patients
    Da Silva, Pedro Ivo
    Figueiredo Modesto, Ana Carolina
    Almeida Matteucci Ferreira, Tatyana Xavier
    Tavares, Renato Sampaio
    Cordeiro de Farias, Danielle Leao
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S333 - S333
  • [28] A RANDOMISED CONTROLLED TRIAL OF AN EDUCATIONAL BOOKLET FOR MULTIPLE MYELOMA PATIENTS WITH PERIPHERAL NEUROPATHY
    Clarke, H. L.
    Gillibrand, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 270 - 270
  • [29] microRNAs as the biomarkers of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma
    Luczkowska, Karolina
    Roginska, Dorota
    Ulanczyk, Zofia
    Safranow, Krzysztof
    Paczkowska, Edyta
    Baumert, Bartlomiej
    Milczarek, Slawomir
    Osekowska, Bogumila
    Gorska, Martyna
    Borowiecka, Ewa
    Sommerfeld, Krzysztof
    Zawodny, Piotr
    Szudy-Szczyrek, Aneta
    Hus, Marek
    Machalinski, Boguslaw
    LEUKEMIA & LYMPHOMA, 2021, 62 (11) : 2768 - 2776
  • [30] Costs associated with treatment induced peripheral neuropathy in patients with multiple myeloma (MM).
    Panjabi, Sumeet
    Song, Xue
    Wilson, Kathleen
    Kagan, Jerry
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345